These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 20549336

  • 1. Relevance of circulating tumor cells, extracellular nucleic acids, and exosomes in breast cancer.
    Friel AM, Corcoran C, Crown J, O'Driscoll L.
    Breast Cancer Res Treat; 2010 Oct; 123(3):613-25. PubMed ID: 20549336
    [Abstract] [Full Text] [Related]

  • 2. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A, Mavroudis D, Perraki M, Apostolaki S, Vlachonikolis I, Lianidou E, Georgoulias V.
    Anticancer Res; 2003 Oct; 23(2C):1883-90. PubMed ID: 12820473
    [Abstract] [Full Text] [Related]

  • 3. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
    Taback B, Chan AD, Kuo CT, Bostick PJ, Wang HJ, Giuliano AE, Hoon DS.
    Cancer Res; 2001 Dec 15; 61(24):8845-50. PubMed ID: 11751407
    [Abstract] [Full Text] [Related]

  • 4. Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.
    Xu Y, Yao L, Li H, Ouyang T, Li J, Wang T, Fan Z, Lin B, Lu Y, Larsson O, Xie Y.
    Breast Cancer Res Treat; 2006 May 15; 97(1):49-55. PubMed ID: 16319978
    [Abstract] [Full Text] [Related]

  • 5. HMGA2 is associated with invasiveness but not a suitable marker for the detection of circulating tumor cells in breast cancer.
    Fabjani G, Tong D, Wolf A, Roka S, Leodolter S, Hoecker P, Fischer MB, Jakesz R, Zeillinger R.
    Oncol Rep; 2005 Sep 15; 14(3):737-41. PubMed ID: 16077985
    [Abstract] [Full Text] [Related]

  • 6. Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.
    Apostolaki S, Perraki M, Kallergi G, Kafousi M, Papadopoulos S, Kotsakis A, Pallis A, Xenidis N, Kalmanti L, Kalbakis K, Agelaki S, Kalykaki A, Stournaras C, Stathopoulos E, Georgoulias V, Mavroudis D.
    Breast Cancer Res Treat; 2009 Oct 15; 117(3):525-34. PubMed ID: 19016323
    [Abstract] [Full Text] [Related]

  • 7. Found in transcription: gene expression and other novel blood biomarkers for the early detection of breast cancer.
    Lönneborg A, Aarøe J, Dumeaux V, Børresen-Dale AL.
    Expert Rev Anticancer Ther; 2009 Aug 15; 9(8):1115-23. PubMed ID: 19671031
    [Abstract] [Full Text] [Related]

  • 8. The clinical significance of circulating tumor cells in the peripheral blood.
    Elshimali YI, Grody WW.
    Diagn Mol Pathol; 2006 Dec 15; 15(4):187-94. PubMed ID: 17122646
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of circulating tumor cells in primary and metastatic breast cancer.
    Aurilio G, Sciandivasci A, Munzone E, Sandri MT, Zorzino L, Cassatella MC, Verri E, Rocca MC, Nolè F.
    Expert Rev Anticancer Ther; 2012 Feb 15; 12(2):203-14. PubMed ID: 22316368
    [Abstract] [Full Text] [Related]

  • 10. Circulating tumor cells in breast cancer.
    Ignatiadis M, Georgoulias V, Mavroudis D.
    Curr Opin Obstet Gynecol; 2008 Feb 15; 20(1):55-60. PubMed ID: 18197007
    [Abstract] [Full Text] [Related]

  • 11. Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood.
    Roncella S, Ferro P, Bacigalupo B, Pronzato P, Tognoni A, Falco E, Gianquinto D, Ansaldo V, Dessanti P, Fais F, Rosai J, Fedeli F.
    J Exp Clin Cancer Res; 2005 Jun 15; 24(2):265-71. PubMed ID: 16110760
    [Abstract] [Full Text] [Related]

  • 12. Free circulating nucleic acids in plasma and serum (CNAPS) -- Useful for the detection of lung cancer patients?
    Fleischhacker M, Schmidt B.
    Cancer Biomark; 2010 Jun 15; 6(3-4):211-9. PubMed ID: 20660966
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic potential of circulating nucleic acids for oncology.
    Goessl C.
    Expert Rev Mol Diagn; 2003 Jul 15; 3(4):431-42. PubMed ID: 12877383
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Soluble VCAM-1 and E-selectin in breast cancer: relationship with staging and with the detection of circulating cancer cells.
    Silva HC, Garcao F, Coutinho EC, De Oliveira CF, Regateiro FJ.
    Neoplasma; 2006 Jul 15; 53(6):538-43. PubMed ID: 17167725
    [Abstract] [Full Text] [Related]

  • 18. Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.
    Marques AR, Teixeira E, Diamond J, Correia H, Santos S, Neto L, Ribeiro M, Miranda A, Passos-Coelho JL.
    Breast Cancer Res Treat; 2009 Mar 15; 114(2):223-32. PubMed ID: 18409061
    [Abstract] [Full Text] [Related]

  • 19. Molecular detection of micrometastases and circulating tumor cells in melanoma prostatic and breast carcinomas.
    Ghossein RA, Carusone L, Bhattacharya S.
    In Vivo; 2000 Mar 15; 14(1):237-50. PubMed ID: 10757082
    [Abstract] [Full Text] [Related]

  • 20. Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel.
    Yeh CS, Wang JY, Wu CH, Chong IW, Chung FY, Wang YH, Yu YP, Lin SR.
    Int J Oncol; 2006 Feb 15; 28(2):411-20. PubMed ID: 16391796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.